BRAX — Braxia Scientific Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual cashflow statement for Braxia Scientific, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.
2019 September 30th | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -0.173 | -88.8 | -12.1 | -13.1 |
| Depreciation | ||||
| Amortisation | ||||
| Deferred Taxes | ||||
| Non-Cash Items | 0.005 | 81.4 | 7.48 | 6.6 |
| Discontinued Operations | ||||
| Unusual Items | ||||
| Equity in Net Earnings/Losses | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | -0.123 | 2.37 | 0.154 | -1.28 |
| Change in Inventories | ||||
| Change in Prepaid Expenses | ||||
| Change in Payable / Accrued Expenses | ||||
| Net Change in Other Assets & Liabilities | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | -0.289 | -5.06 | -4.52 | -7.4 |
| Capital Expenditures | -0.06 | — | -0.025 | -0.903 |
| Purchase of Fixed Assets | ||||
| Purchase / Acquisition of Intangibles | ||||
| Other Investing Cash Flow Items | — | -1.31 | -0.584 | -0.226 |
| Acquisition of Business | ||||
| Sale of Business | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | -0.06 | -1.31 | -0.609 | -1.13 |
| Financing Cash Flow Items | 1.2 | 0.275 | 0 | — |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 1.2 | 14.4 | 2.7 | 1.24 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 0.856 | 8.05 | -2.42 | -7.22 |